Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US FDA requests Endo Pharmaceuticals to remove Opana ER for risks related to abuse

biospectrumasiaJune 13, 2017

Tag: pharmaceutical

PharmaSources Customer Service